| Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ... The Lancet 395 (10241), 1907-1918, 2020 | 1885 | 2020 |
| Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy Y Min, KC Roche, S Tian, MJ Eblan, KP McKinnon, JM Caster, S Chai, ... Nature nanotechnology 12 (9), 877-882, 2017 | 618 | 2017 |
| Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials JM Caster, AN Patel, T Zhang, A Wang Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 9 (1), e1416, 2017 | 445 | 2017 |
| Combination strategies to maximize the benefits of cancer immunotherapy S Zhu, T Zhang, L Zheng, H Liu, W Song, D Liu, Z Li, C Pan Journal of hematology & oncology 14 (1), 156, 2021 | 353 | 2021 |
| Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium P Grivas, AR Khaki, TM Wise-Draper, B French, C Hennessy, CY Hsu, ... Annals of oncology 32 (6), 787-800, 2021 | 304 | 2021 |
| A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial SK Pal, C Tangen, IM Thompson, N Balzer-Haas, DJ George, DYC Heng, ... The Lancet 397 (10275), 695-703, 2021 | 216 | 2021 |
| Neuroendocrine prostate cancer: subtypes, biology, and clinical outcomes R Aggarwal, T Zhang, EJ Small, AJ Armstrong Journal of the National Comprehensive Cancer Network 12 (5), 719-726, 2014 | 211 | 2014 |
| Folate-targeted nanoparticle delivery of chemo-and radiotherapeutics for the treatment of ovarian cancer peritoneal metastasis ME Werner, S Karve, R Sukumar, ND Cummings, JA Copp, RC Chen, ... Biomaterials 32 (33), 8548-8554, 2011 | 200 | 2011 |
| Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised … T Powles, P Tomczak, SH Park, B Venugopal, T Ferguson, ... The lancet oncology 23 (9), 1133-1144, 2022 | 189 | 2022 |
| Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19 MA Thompson, JP Henderson, PK Shah, SM Rubinstein, MJ Joyner, ... JAMA oncology 7 (8), 1167-1175, 2021 | 186 | 2021 |
| Clinical activity of nivolumab in patients with non-clear cell renal cell carcinoma VS Koshkin, PC Barata, T Zhang, DJ George, MB Atkins, WJ Kelly, ... Journal for immunotherapy of cancer 6, 1-7, 2018 | 175 | 2018 |
| Management of metastatic clear cell renal cell carcinoma: ASCO guideline WK Rathmell, RB Rumble, PJ Van Veldhuizen, H Al-Ahmadie, ... Journal of Clinical Oncology 40 (25), 2957-2995, 2022 | 166 | 2022 |
| Biomarkers of immunotherapy in urothelial and renal cell carcinoma: PD-L1, tumor mutational burden, and beyond J Zhu, AJ Armstrong, TW Friedlander, W Kim, SK Pal, DJ George, T Zhang Journal for immunotherapy of cancer 6, 1-10, 2018 | 149 | 2018 |
| COVID-19 vaccines for patients with cancer: benefits likely outweigh risks JK Hwang, T Zhang, AZ Wang, Z Li Journal of hematology & oncology 14, 1-11, 2021 | 143 | 2021 |
| Folate-targeted pH-responsive calcium zoledronate nanoscale metal-organic frameworks: turning a bone antiresorptive agent into an anticancer therapeutic KM Au, A Satterlee, Y Min, X Tian, YS Kim, JM Caster, L Zhang, T Zhang, ... Biomaterials 82, 178-193, 2016 | 116 | 2016 |
| Novel therapies are changing treatment paradigms in metastatic prostate cancer E Powers, GS Karachaliou, C Kao, MR Harrison, CJ Hoimes, DJ George, ... Journal of hematology & oncology 13, 1-13, 2020 | 104 | 2020 |
| Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors JM Conroy, S Pabla, MK Nesline, ST Glenn, A Papanicolau-Sengos, ... Journal for immunotherapy of cancer 7, 1-11, 2019 | 94 | 2019 |
| Phase II study of gemcitabine and split-dose cisplatin plus pembrolizumab as neoadjuvant therapy before radical cystectomy in patients with muscle-invasive bladder cancer TL Rose, MR Harrison, AM Deal, S Ramalingam, YE Whang, B Brower, ... Journal of Clinical Oncology 39 (28), 3140-3148, 2021 | 93 | 2021 |
| Organ-specific metastases obtained by culturing colorectal cancer cells on tissue-specific decellularized scaffolds X Tian, ME Werner, KC Roche, AD Hanson, HP Foote, SK Yu, SB Warner, ... Nature biomedical engineering 2 (6), 443-452, 2018 | 92 | 2018 |
| Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients S Pabla, JM Conroy, MK Nesline, ST Glenn, A Papanicolau-Sengos, ... Journal for immunotherapy of cancer 7, 1-13, 2019 | 89 | 2019 |
